THERAPEUTIC AGENT FOR HIGH-RISK MYELOFIBROSIS
The present invention relates to a novel therapeutic agent for high-risk myelofibrosis, said agent containing a compound represented by general formula [1] (in the formula, R1, R2, R3, R4, R5, and X are as defined in the description) or a pharmaceutically acceptable salt thereof as an active ingredi...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; jpn |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!